Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_assertion type Assertion NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_head.
- NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_assertion description "[Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_provenance.
- NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_assertion evidence source_evidence_literature NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_provenance.
- NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_assertion SIO_000772 22372203 NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_provenance.
- NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_assertion wasDerivedFrom befree-20150227 NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_provenance.
- NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_assertion wasGeneratedBy ECO_0000203 NP292352.RAB1BSm-pLD3SYHiAnfjoTiyHLba0UpXGj5si5iIHYBmM130_provenance.